Clinic
Mercy Medical Health Center
Mercy Medical Health Center was paid $8.51M by Medicaid between Jan 2018 and Dec 2024, across 96 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 99% of everything it billed.
33Billing provider infoMERCY MEDICAL HEALTH CENTER
JONESBORO, LA 71251
JONESBORO, LA 71251
33aNPI1063945434assigned 04/04/2017
33bProvider typeCommunity Health Clinic/Center
28Total paid$8.51M
24GClaims237,254
24DCodes billed96
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community Health Clinic/Center providers in Louisiana
Rank by total paid#1 of 9
Median peer was paid$127K
This provider vs. median67×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,503 | $257K | |
| 2019 | 18,946 | $718K | |
| 2020 | 26,135 | $955K | |
| 2021 | 39,052 | $1.46M | |
| 2022 | 53,841 | $1.63M | |
| 2023 | 53,006 | $1.71M | |
| 2024incomplete | 34,771 | $1.78M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 99% | 84,550 | 51,269 | $8.42M |
| H2020 | Therapeutic behavioral services, per diem | <1% | 739 | 371 | $85K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 50,201 | 31,888 | $7K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 19,170 | 12,994 | $1K |
| 99050 | <1% | 49 | 22 | $214.80 | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 1,526 | 1,193 | $184.06 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,558 | 936 | $169.72 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 8,791 | 6,558 | $130.46 |
| 96127 | <1% | 9,870 | 6,921 | $118.22 | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 476 | 358 | $77.25 |
| 3044F | <1% | 849 | 625 | $60.00 | |
| 90756 | <1% | 274 | 160 | $45.58 |
84 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,410 | $35.51 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,696 | $34.13 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 2,233 | $25.30 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 187 | $14.70 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,422 | $10.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 442 | $8.26 |
| 3077F | <1% | 251 | $5.00 | |
| 99408 | <1% | 3,460 | $3.75 | |
| 81003 | <1% | 1,516 | $2.24 | |
| 81002 | <1% | 49 | $2.03 | |
| 99173 | <1% | 1,883 | $1.91 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,553 | $0.92 |
| 96160 | 0% | 6,205 | $0.00 | |
| 92552 | 0% | 1,623 | $0.00 | |
| 90461 | 0% | 1,197 | $0.00 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 457 | $0.00 |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | 0% | 667 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 896 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 179 | $0.00 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 386 | $0.00 |
| 81025 | 0% | 564 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 39 | $0.00 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 446 | $0.00 |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 170 | $0.00 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 105 | $0.00 |
| 90633 | 0% | 61 | $0.00 | |
| 90671 | 0% | 38 | $0.00 | |
| 90791 | Psychiatric diagnostic evaluation | 0% | 155 | $0.00 |
| 90734 | 0% | 79 | $0.00 | |
| S0028 | Injection, famotidine, 20 mg | 0% | 24 | $0.00 |
| 90670 | 0% | 153 | $0.00 | |
| 90837 | Psychotherapy session, about an hour | 0% | 87 | $0.00 |
| 90649 | 0% | 103 | $0.00 | |
| 99177 | 0% | 148 | $0.00 | |
| 83655 | 0% | 63 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 360 | $0.00 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 61 | $0.00 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 118 | $0.00 |
| 82948 | 0% | 104 | $0.00 | |
| 0002A | 0% | 21 | $0.00 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | 0% | 140 | $0.00 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 152 | $0.00 |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 13 | $0.00 |
| J2010 | Injection, lincomycin hcl, up to 300 mg | 0% | 21 | $0.00 |
| 90700 | 0% | 15 | $0.00 | |
| 90710 | 0% | 14 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 29 | $0.00 |
| 3078F | 0% | 39 | $0.00 | |
| D0145 | Oral evaluation for a patient under three years of age | 0% | 69 | $0.00 |
| 99442 | 0% | 15 | $0.00 | |
| 99000 | 0% | 2,909 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 2,557 | $0.00 |
| 90674 | 0% | 61 | $0.00 | |
| G0467 | Community health center visit, returning patient | 0% | 1,759 | $0.00 |
| 3074F | 0% | 289 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 2,497 | $0.00 |
| 85018 | 0% | 1,992 | $0.00 | |
| 3079F | 0% | 530 | $0.00 | |
| 36416 | 0% | 491 | $0.00 | |
| 3048F | 0% | 365 | $0.00 | |
| 90686 | 0% | 383 | $0.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 1,526 | $0.00 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 25 | $0.00 |
| H0049 | Alcohol and/or drug screening | 0% | 86 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 25 | $0.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 118 | $0.00 |
| 3049F | 0% | 132 | $0.00 | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 0% | 40 | $0.00 |
| 0012A | 0% | 49 | $0.00 | |
| 0011A | 0% | 49 | $0.00 | |
| 3080F | 0% | 110 | $0.00 | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 0% | 523 | $0.00 |
| 99174 | 0% | 658 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 18 | $0.00 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 315 | $0.00 |
| 3075F | 0% | 79 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 108 | $0.00 |
| 99441 | 0% | 155 | $0.00 | |
| 90620 | 0% | 27 | $0.00 | |
| 92551 | 0% | 39 | $0.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 84 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 51 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 19 | $0.00 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRUNSON, KIMBERLY (CEO, NP)
| Provider | Location | Paid |
|---|---|---|
| Mercy Medical Health Center | Ruston, LA | $512K |
| Mercy Medical Health Center of Gulf Shores | Gulf Shores, AL | $19K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.